Sheppard D N, Ostedgaard L S
Department of Medicine, University of Edinburgh, Western General Hospital, UK.
Mol Med Today. 1996 Jul;2(7):290-7. doi: 10.1016/1357-4310(96)10028-9.
Defective epithelial Cl- secretion is the hallmark of the lethal genetic disease cystic fibrosis (CF). This abnormality is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a regulated Cl- channel. Since the identification of the single gene encoding CFTR, several hundred disease-causing mutations, associated with a wide variety of clinical phenotypes, have been reported. To understand the relationship between genotype and clinical phenotype, researchers have investigated how mutations in CFTR disrupt its function. Here, we review the recent progress in understanding how CF-associated mutations in CFTR produce defective Cl- channels, and discuss the implications of this knowledge for the development of therapy for CF.
上皮细胞氯离子分泌缺陷是致命性遗传病囊性纤维化(CF)的标志。这种异常是由囊性纤维化跨膜传导调节因子(CFTR)的突变引起的,CFTR是一种受调控的氯离子通道。自编码CFTR的单基因被鉴定以来,已经报道了数百种与多种临床表型相关的致病突变。为了理解基因型与临床表型之间的关系,研究人员研究了CFTR中的突变如何破坏其功能。在这里,我们回顾了在理解CFTR中与CF相关的突变如何产生有缺陷的氯离子通道方面的最新进展,并讨论了这些知识对CF治疗发展的意义。